Gabriel Paiva Da Silva Lima

9PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Traditional, complementary and integrative medicine not elsewhere classifiedPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 28, 2026
Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial.

|Nov 03, 2025
Efficacy and Safety of Very Low Achieved LDL Cholesterol in Patients With Previous Ischemic Stroke.

Victorien Monguillon, Peter J Kelly, Michelle L O'Donoghue

|Oct 14, 2025
Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study.

Gabriel Paiva da Silva Lima, Renata Rao, Gyöngyi Szabó

|Jul 30, 2025
Characterisation of a clinical trial-like population of high cardiovascular risk patients prior to myocardial infarction or stroke in the real world: design and protocol for a multidatabase retrospective cohort study.

Andreas Ochs, Queenie Chan, Nafeesa N Dhalwani

|Mar 13, 2024
Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open-label, multiple-dose study.

Andrew D Hershey, Gabriel Paiva da Silva Lima, Nicola Pannacciulli

|Aug 19, 2023
Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trial.

Koichi Hirata, Takao Takeshima, Fumihiko Sakai

Pageof 2

Frequent Collaborators

2 joint publications

Robert P Giugliano

2 joint publications

Marc S Sabatine

2 joint publications

Erin A Bohula

2 joint publications

Jeong-Gun Park